Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEnterprise ValueEquity AverageInventory AverageInvested CapitalMarket Capitalization

Zhengye Biotechnology Holding (ZYBT) Equity Average: 2024-2025

  • Zhengye Biotechnology Holding's Equity Average was N/A to $49.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $49.4 million, marking a year-over-year change of. This contributed to the annual value of $48.2 million for FY2024, which is 4.79% down from last year.
  • As of Q2 2025, Zhengye Biotechnology Holding's Equity Average stood at $49.4 million, which was up 3.52% from $47.7 million recorded in Q4 2024.
  • In the past 5 years, Zhengye Biotechnology Holding's Equity Average registered a high of $49.4 million during Q2 2025, and its lowest value of $47.7 million during Q4 2024.
  • Moreover, its 2-year median value for Equity Average was $48.5 million (2024), whereas its average is $48.5 million.